Medicines360, a non-profit pharmaceutical company, and Actavis, Inc., a global specialty pharmaceutical company, today announced a historic partnership to support Medicines360's mission to reduce cost as a barrier to accessing women's birth control. The Medicines360 and Actavis partnership will make the IUD available in the U.S. commercially and at a very low price in U.S. public sector clinics.
Federal prosecutors in New Jersey say a former executive for biopharmaceuticals company Bristol-Myers Squibb has admitted using his high-level position and access to nonpublic information to make about $310,000 from insider trades. Robert Ramnarine pleaded guilty Monday to securities fraud. The...
With the flat fascia Vision350™ P66/IP65/NEMA4X rating, these units are ideal wherever spray/wipe down applications apply. The PLC + HMI advantage gives users the opportunity to operate on a minimum of budget, programming time and wiring.
The 90° peel fixture for use with the CT3 tester is designed to measure the adhesion force between two materials. The fixture maintains a 90° angle as the tape is pulled away from the substrate.
Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries. The company said Vitaros is now approved in the Netherlands, Germany, France, Italy, and the U.K., among other countries, for the treatment of erectile dysfunction. Apricus sought...
Belviq will be available to U.S. patients this next week, nearly a year after the drug was officially approved by federal regulators. The FDA approved Belviq last June for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol.
Bringing a new medicine to market in Africa requires 54 separate applications to each country on the continent, a time-intensive process that could be costing lives. African leaders are now trying to move toward a regional and eventually continentwide approach to speed the process.
A bill that is intended to persuade more Oregon parents to take their kids to doctors for shots and get over their mistrust of conventional medicine has taken a big step in the Legislature with passage by the state Senate. Oregon has the nation's highest rate of parents refusing vaccinations for their kindergartners for nonmedical reasons.
Cumberland Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Acetadote (acetylcysteine) Injection. The new labeling revises the product's indication and offers new dosing guidance for specific patient populations.
The Food and Drug Administration said in an online posting Friday that it identified the growths in two unopened vials of a steroid injection distributed by the Main Street Family Pharmacy, a compounding pharmacy in Newbern, Tenn. The agency said it is working with the Centers for Disease Control and Prevention to identify the exact species of fungus and bacteria.
Arden Stickel is worried. He's getting on in years and won't be around forever, so he's got to figure out what to do with all his Miles Laboratories bottles and pills. And promotional Frisbees. And company newsletters. And Speedy dolls, Speedy being the Alka-Seltzer pitchman of yesteryear.
The board of directors of the Irish drugmaker Elan Corp. PLC on Monday rejected an increased offer from Royalty Pharma and says it has received unsolicited interest from other parties it didn't name. Royalty's latest offer last week was for $13 per share plus up to $2.50 per share in payments based on performance milestones. That offer totaled about $7.76 billion not counting the milestone payments.
AstraZeneca announced today that it has entered into a definitive agreement to acquire Pearl Therapeutics, a privately held company based in Redwood City, California, focused on the development of inhaled small-molecule therapeutics for respiratory disease.
Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators. The Food and Drug Administration approved Belviq last June for adults who are obese or who are overweight and...